The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent

[18F]NaF PET/CT scan as an early marker of heterotopic ossification in fibrodysplasia ossificans progressiva

(2018) E. Marelise W. Eekhoff et al.   BONE

Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling

(2016) Haitao Wang et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification

(2016) D. Dey et al.   Science Translational Medicine

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B

(2015) Oddrun Elise Olsen et al.   Cell Communication and Signaling

The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global Assessment

(2015) Robert J Pignolo et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Neofunction of ACVR1 in fibrodysplasia ossificans progressiva

(2015) Kyosuke Hino et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

ACVR1 R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A

(2015) Sarah J. Hatsell et al.   Science Translational Medicine

The phenotype and genotype of fibrodysplasia ossificans progressiva in China: A report of 72 cases

(2013) Wei Zhang et al.   BONE

Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: an open-labeled clinical trial

(2013) Hiroshi Kitoh et al.   Orphanet Journal of Rare Diseases

AnAcvr1R206H knock-in mouse has fibrodysplasia ossificans progressiva

(2012) Salin A Chakkalakal et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair

(2011) David M. de Kretser et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Inherited human diseases of heterotopic bone formation

(2010) Eileen M. Shore et al.   Nature Reviews Rheumatology